Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Glaser

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
ALTEX|January 1, 1996
[Maximum Likelihood classification rule for assessing acute toxicity]Sabine Glaser, Hartmut Hecker
Preventive Veterinary Medicine|June 19, 2002
Calculating sample size bounds for logistic regressionSusanne Broll, Sabine Glaser, Lothar Kreienbrock
Acta Haematologica|July 4, 2015
Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare AnemiasYutaka Kohgo, Akio Urabe, Yurdanur Kilinç, et al.
American Journal of Epidemiology|December 13, 2006
Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groupsDirk Werber, Susanne C Behnke, Angelika Fruth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2018
Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung CancerYi-Long Wu, Li Zhang, Dong-Wan Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2024
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancerEnriqueta Felip, Giulio Metro, Ross A Soo, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
ALTEX|January 1, 1996
[Maximum Likelihood classification rule for assessing acute toxicity]Sabine Glaser, Hartmut Hecker
Preventive Veterinary Medicine|June 19, 2002
Calculating sample size bounds for logistic regressionSusanne Broll, Sabine Glaser, Lothar Kreienbrock
Acta Haematologica|July 4, 2015
Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare AnemiasYutaka Kohgo, Akio Urabe, Yurdanur Kilinç, et al.
American Journal of Epidemiology|December 13, 2006
Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groupsDirk Werber, Susanne C Behnke, Angelika Fruth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2018
Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung CancerYi-Long Wu, Li Zhang, Dong-Wan Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2024
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancerEnriqueta Felip, Giulio Metro, Ross A Soo, et al.
Pageof 1